From Nasdaq: 2024-04-10 07:45:00

Walgreens Boots Alliance (NASDAQ: WBA) is facing financial struggles, cutting its dividend and venturing further into healthcare. CEO Tim Wentworth believes the company’s human touch will provide an edge over tech-based competitors like Amazon (NASDAQ: AMZN).

Walgreens is investing $5.2 billion into primary-care provider VillageMD, aiming to open clinics at 1,000 locations by 2027. Despite recent losses in the healthcare business, CEO Wentworth sees long-term potential in this strategy to attract investors.

However, Walgreens’ future remains uncertain, with declining financial performance and stock value. As Amazon expands its healthcare presence, investors are advised to be cautious and consider other investment opportunities. Walgreens may struggle to compete in the rapidly evolving healthcare landscape.



Read more at Nasdaq: This Is How Walgreens’ New CEO Thinks the Company Can Beat Amazon